• Zealand Pharma average ebitda margin for 2023 was -438.53%, a 30.32% decline from 2022.
• Zealand Pharma average ebitda margin for 2022 was -629.35%, a 90.29% decline from 2021.
• Zealand Pharma average ebitda margin for 2021 was -330.74%, a 26.48% increase from 2020.

Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.